<VariationArchive VariationID="2424170" VariationName="NC_000023.10:g.(?_153592874)_(153593874_?)del" VariationType="Deletion" Accession="VCV002424170" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1939327" VariationID="2424170">
      <GeneList>
        <Gene Symbol="FLNA" FullName="filamin A" GeneID="2316" HGNC_ID="HGNC:3754" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154348531" stop="154374634" display_start="154348531" display_stop="154374634" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153576899" stop="153603005" display_start="153576899" display_stop="153603005" Strand="-" />
          </Location>
          <OMIM>300017</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FLNA">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-02" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FLNA">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000023.10:g.(?_153592874)_(153593874_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" innerStart="153592874" innerStop="153593874" display_start="153592874" display_stop="153593874" variantLength="1001" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.(?_153592874)_(153593874_?)del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.(?_153592874)_(153593874_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.10:g.(?_153592874)_(153593874_?)del AND multiple conditions" Accession="RCV003107403" Version="4">
        <ClassifiedConditionList TraitSetID="53144">
          <ClassifiedCondition DB="MedGen" ID="C0265293">Frontometaphyseal dysplasia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1848213">Heterotopia, periventricular, X-linked dominant</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0025237">Melnick-Needles syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1844696">Oto-palato-digital syndrome, type II</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-10-26" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16684786</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20730588</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26471271</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="53144" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1645" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PERIVENTRICULAR NODULAR HETEROTOPIA 1</ElementValue>
                <XRef Type="MIM" ID="300049" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked periventricular heterotopia</ElementValue>
                <XRef ID="X-linked+periventricular+heterotopia/7556" DB="Genetic Alliance" />
                <XRef ID="448227009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Heterotopia familial nodular</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nodular heterotopia bilateral periventricular</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PERIVENTRICULAR NODULAR HETEROTOPIA 4</ElementValue>
                <XRef Type="MIM" ID="300049" DB="OMIM" />
                <XRef Type="MIM" ID="300537" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HETEROTOPIA, PERIVENTRICULAR, 1</ElementValue>
                <XRef Type="Allelic variant" ID="300017.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300017.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300017.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300017.0018" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Heterotopia, periventricular, X-linked dominant</ElementValue>
                <XRef ID="MONDO:0010233" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NHBP</ElementValue>
                <XRef Type="MIM" ID="300049" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">BPNH</ElementValue>
                <XRef Type="MIM" ID="300049" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">PVNH1</ElementValue>
                <XRef Type="MIM" ID="300049" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PVNH4</ElementValue>
                <XRef Type="MIM" ID="300537" DB="OMIM" />
                <XRef Type="MIM" ID="300049" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">FLNA deficiency is associated with a phenotypic spectrum that includes FLNA-related periventricular nodular heterotopia (Huttenlocher syndrome), congenital heart disease (patent ductus arteriosus, atrial and ventricular septal defects), valvular dystrophy, dilation and rupture of the thoracic aortic, pulmonary disease (pulmonary hypertension, alveolar hypoplasia, emphysema, asthma, chronic bronchitis), gastrointestinal dysmotility and obstruction, joint hypermobility, and macrothrombocytopenia.</Attribute>
                <XRef ID="NBK1213" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">FLNA-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">FLNA-Related Periventricular Nodular Heterotopia</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7371" />
                <XRef ID="7371" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301392</ID>
                <ID Source="BookShelf">NBK1213</ID>
              </Citation>
              <XRef ID="2149" DB="Orphanet" />
              <XRef ID="82004" DB="Orphanet" />
              <XRef ID="C1848213" DB="MedGen" />
              <XRef ID="MONDO:0010233" DB="MONDO" />
              <XRef Type="MIM" ID="300049" DB="OMIM" />
            </Trait>
            <Trait ID="2842" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Melnick-Needles syndrome</ElementValue>
                <XRef ID="Melnick-Needles+syndrome/4587" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010650" DB="MONDO" />
                <XRef ID="13449007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Melnick-Needles osteodysplasty</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteodysplasty of Melnick and Needles</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MNS</ElementValue>
                <XRef Type="MIM" ID="309350" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The X-linked otopalatodigital (X-OPD) spectrum disorders, characterized primarily by skeletal dysplasia, include the following: Otopalatodigital syndrome type 1 (OPD1). Otopalatodigital syndrome type 2 (OPD2). Frontometaphyseal dysplasia type 1 (FMD1). Melnick-Needles syndrome (MNS). Terminal osseous dysplasia with pigmentary skin defects (TODPD). In OPD1, most manifestations are present at birth; females can present with severity similar to affected males, although some have only mild manifestations. In OPD2, females are less severely affected than related affected males. Most males with OPD2 die during the first year of life, usually from thoracic hypoplasia resulting in pulmonary insufficiency. Males who live beyond the first year of life are usually developmentally delayed and require respiratory support and assistance with feeding. In FMD1, females are less severely affected than related affected males. Males do not experience a progressive skeletal dysplasia but may have joint contractures and hand and foot malformations. Progressive scoliosis is observed in both affected males and females. In MNS, wide phenotypic variability is observed; some individuals are diagnosed in adulthood, while others require respiratory support and have reduced longevity. MNS in males results in perinatal lethality in all recorded cases. TODPD, seen only in females, is characterized by a skeletal dysplasia that is most prominent in the digits, pigmentary defects of the skin, and recurrent digital fibromata.</Attribute>
                <XRef ID="NBK1393" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">FLNA-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7011" />
                <XRef ID="7011" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301567</ID>
                <ID Source="BookShelf">NBK1393</ID>
              </Citation>
              <XRef ID="2484" DB="Orphanet" />
              <XRef ID="C0025237" DB="MedGen" />
              <XRef ID="MONDO:0010650" DB="MONDO" />
              <XRef Type="MIM" ID="309350" DB="OMIM" />
            </Trait>
            <Trait ID="3340" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">OPD II SYNDROME</ElementValue>
                <XRef Type="MIM" ID="304120" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Oto-palato-digital syndrome type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Andre syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OPD 2 syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cranio-oro-digital syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Faciopalatoosseous syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Otopalatodigital Syndrome, Type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Oto-palato-digital syndrome, type II</ElementValue>
                <XRef ID="Oto-palato-digital+syndrome+type+2/5496" DB="Genetic Alliance" />
                <XRef ID="42432003" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FPO</ElementValue>
                <XRef Type="MIM" ID="304120" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">OPD2</ElementValue>
                <XRef Type="MIM" ID="304120" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The X-linked otopalatodigital (X-OPD) spectrum disorders, characterized primarily by skeletal dysplasia, include the following: Otopalatodigital syndrome type 1 (OPD1). Otopalatodigital syndrome type 2 (OPD2). Frontometaphyseal dysplasia type 1 (FMD1). Melnick-Needles syndrome (MNS). Terminal osseous dysplasia with pigmentary skin defects (TODPD). In OPD1, most manifestations are present at birth; females can present with severity similar to affected males, although some have only mild manifestations. In OPD2, females are less severely affected than related affected males. Most males with OPD2 die during the first year of life, usually from thoracic hypoplasia resulting in pulmonary insufficiency. Males who live beyond the first year of life are usually developmentally delayed and require respiratory support and assistance with feeding. In FMD1, females are less severely affected than related affected males. Males do not experience a progressive skeletal dysplasia but may have joint contractures and hand and foot malformations. Progressive scoliosis is observed in both affected males and females. In MNS, wide phenotypic variability is observed; some individuals are diagnosed in adulthood, while others require respiratory support and have reduced longevity. MNS in males results in perinatal lethality in all recorded cases. TODPD, seen only in females, is characterized by a skeletal dysplasia that is most prominent in the digits, pigmentary defects of the skin, and recurrent digital fibromata.</Attribute>
                <XRef ID="NBK1393" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">FLNA-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5802" />
                <XRef ID="5802" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301567</ID>
                <ID Source="BookShelf">NBK1393</ID>
              </Citation>
              <XRef ID="669" DB="Orphanet" />
              <XRef ID="90652" DB="Orphanet" />
              <XRef ID="C1844696" DB="MedGen" />
              <XRef ID="MONDO:0010571" DB="MONDO" />
              <XRef Type="MIM" ID="304120" DB="OMIM" />
            </Trait>
            <Trait ID="43500" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Frontometaphyseal dysplasia</ElementValue>
                <XRef ID="Frontometaphyseal+Dysplasia/2937" DB="Genetic Alliance" />
                <XRef ID="MONDO:0015942" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS305620" DB="OMIM" />
                <XRef ID="62803002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FMD</ElementValue>
                <XRef Type="MIM" ID="305620" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">FMD1</ElementValue>
                <XRef ID="GTR000519546" DB="Genetic Testing Registry (GTR)" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="826" />
                <XRef ID="826" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1826" DB="Orphanet" />
              <XRef ID="C0265293" DB="MedGen" />
              <XRef ID="MONDO:0015942" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS305620" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7073009" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_001456.3_X_Deletion (exons 10-13)|MedGen:C1844696;C1848213;C0265293;C0025237" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003793584" DateUpdated="2024-06-09" DateCreated="2023-02-13" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16684786</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20730588</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26471271</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with FLNA-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 10-13 of the FLNA gene. This deletion is out-of-frame, and is expected to create a premature termination codon and result in an absent or disrupted protein product. Loss-of-function variants in FLNA are known to be pathogenic (PMID: 16684786, 20730588, 26471271).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLNA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_153592874)_(153593874_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1844696" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1848213" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265293" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0025237" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7073009" TraitType="Disease" MappingType="XRef" MappingValue="C1844696" MappingRef="MedGen">
        <MedGen CUI="C1844696" Name="Oto-palato-digital syndrome, type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7073009" TraitType="Disease" MappingType="XRef" MappingValue="C1848213" MappingRef="MedGen">
        <MedGen CUI="C1848213" Name="Heterotopia, periventricular, X-linked dominant" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7073009" TraitType="Disease" MappingType="XRef" MappingValue="C0265293" MappingRef="MedGen">
        <MedGen CUI="C0265293" Name="Frontometaphyseal dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7073009" TraitType="Disease" MappingType="XRef" MappingValue="C0025237" MappingRef="MedGen">
        <MedGen CUI="C0025237" Name="Melnick-Needles syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

